Abstract:Objective To investigate the species composition and dynamic changes of vaginal microbiota in patients with recurrent vulvovaginal candidiasis （RVVC）. Methods Six patients with confirmed symptomatic RVVC were enrolled in this study. During the onset of RVVC, 1 high vaginal swab sample was collected from each patient on a daily basis to identify the vaginal microbiota. Principal co-ordinate analysis （PCoA）, thermogram analysis and α diversity analysis were adopted to analyze the species composition and dynamic changes of vaginal microbiota in RVVC patients. Results PCoA analysis between groups showed that the species composition of vaginal microbiota in patients with RVVC was similar at the interval between onset, but the species difference was increased at several days before the onset and on the day of onset. Thermogram analysis suggested that the distance between microbiota was large in the onset stage and at the interval between onset of RVVC, and the intermediate difference of microbiota began to converge at several days before the onset stage. The species composition analysis of vaginal microbiota in patients with RVVC showed that Lactobacillus accounted for 64.25%. Bacterial genera with relative abundance between 0.10% and 1.00% included Dialister, Enterobacteriaceae, Finegoldia magna, Atopobium, Aerococcus, Staphylococcus, Anaerococcus and Lactococcus. The genera with relative abundance of >1.00% consisted of Lactobacillus, Prevotella, Streptococcus, Gardnerella and Ureaplasma. The α diversity index evaluation results indicated that the species abundance at the interval between onset of RVVC was similar, which was increased approaching the onset stage, and most returned to a low level of species abundance before the onset. Lactobacillus was the absolute dominant genus during several menstrual cycles of patients receiving follow-up, with small fluctuations. However, there was a transient increase of Prevotella in each group before the onset, and there was also an increase in Gardnerella, which occasionally fluctuated. The proportion of the other genera such as Dialister, Finegoldia magna, Atopobium and Ureaplasma was relatively low,and with few fluctuations. The remaining genera remained at a low level during the menstrual cycle.Conclusions Lactobacillus is the main vaginal microbiota in patients with RVVC. Vaginal microbiota in RVVC patients are relatively stable, with few fluctuations. In clinical treatment,widespread attention should be diverted to the regulation of vaginal microecological environment and restoring the proportion of vaginal microbiota.

Candida causes recurrent vulvovaginal candidiasis by forming morphologically disparate biofilms on the human vaginal epithelium

Highlight signatures of vaginal microbiota and metabolome contributed to the occurrence and recurrence of vulvovaginal candidiasis

Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance

Inflammatory invasion on human vaginal mucosa correlated with combined drug treatment and recurrence in recurrent vulvovaginal candidiasis

[Longitudinal Analysis of Vaginal Microbiota in Women with Recurrent Vulvovaginal Candidiasis].

Landscape of In Situ Cytokine Expression, Soluble C-type Lectin Receptors, and Vitamin D in Patients with Recurrent Vulvovaginal Candidiasis

Vulvovaginal Candidiasis: Histologic Lesions Are Primarily Polymicrobial and Invasive and Do Not Contain Biofilms

[Analysis of Homology and Drug Sensitivity of Vaginal Isolates of 10 Patients with Recurrent Vulvovaginal Candidiasis in Recurrent Episodes].

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis

Increasing rate of non- Candida albicans yeasts and fluconazole resistance in yeast isolates from women with recurrent vulvovaginal candidiasis in Leeds, United Kingdom

RAFT-Derived Polymethacrylates as a Superior Treatment for Recurrent Vulvovaginal Candidiasis by Targeting Biotic Biofilms and Persister Cells

Investigate the Pathogen Flora and the Treatment of Recurrent Vulvovaginal Candidiasis

The Increasing Trend of Triazole-Resistant Candida from Vulvovaginal Candidiasis

Recurrent genital 45 cases of vaginal Candida disease clinical treatment experience

The Antibiofilm Role of Biotics Family in Vaginal Fungal Infections

Antifungal susceptibility and biofilm production of Candida species- causative agents of female genital tract infections

Patients with recurrent vulvovaginal candidiasis exhibit a decrease in both the fungicidal activity of neutrophils and the proliferation of peripheral blood mononuclear cells

Up-regulation of CDR1 and MDR1 efflux pump genes and fluconazole resistance are involved in recurrence in Candida albicans-induced vulvovaginal candidiasis

Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections

Species composition and dynamic changes of vaginal microbiota in patients with recurrent vulvovaginal candidiasis

Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review